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Abstract The emerging concept of systems medicine (or
‘P4 medicine’—predictive, preventive, personalized and
participatory) is at the vanguard of the post-genomic
movement towards ‘precision medicine’. It is the medical
application of systems biology, the biological study of
wholes. Of particular interest, P4 systems medicine is cur-
rently promised as a revolutionary new biomedical
approach that is holistic rather than reductionist. This article
analyzes its concept of holism, both with regard to methods
and conceptualization of health and disease. Rather than
representing a medical holism associated with basic
humanistic ideas, we find a technoscientific holism resulting
from altered technological and theoretical circumstances in
biology. We argue that this holism, which is aimed at dis-
ease prevention and health optimization, points towards an
expanded form of medicalization, which we call ‘holistic
medicalization’: Each person’s whole life process is defined
in biomedical, technoscientific terms as quantifiable and
controllable and underlain a regime of medical control that
is holistic in that it is all-encompassing. It is directed at all
levels of functioning, from the molecular to the social,
continual throughout life and aimed at managing the whole
continuum from cure of disease to optimization of health.
We argue that this medicalization is a very concrete mate-
rialization of a broader trend in medicine and society, which
we call ‘the medicalization of health and life itself’. We
explicate this holistic medicalization, discuss potential
harms and conclude by calling for preventive measures
aimed at avoiding eventual harmful effects of overmedi-
calization in systems medicine (quaternary prevention).
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Systems medicine
It is possible to get the life-phenomenon under our
control … such a control and nothing else is the aim
of biology—Biologist Jacques Loeb (1859–1924)
(cited in Pauly 1987, p. 174).
At the risk of sounding academic, you are a system. A
system made up of systems, to be exact. … Our
integrative—or systems—approach holistically gath-
ers, connects, and analyzes your data to create a
complete picture of you, all 360 degrees of you ... At
Arivale, we don’t guess. We base our recommenda-
tions—your roadmap—on your personal data story,
that 360-degree view of you consisting of millions of
data points.—The website of the P4 systems medi-
cine company Arivale (2015).
Introduction
This paper is motivated by authoritative claims that med-
icine, and especially primary care, will soon undergo a
technologically driven system change associated with
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buzzwords such as ‘genomics’, ‘big data’, ‘digital health’
and ‘personalized’ or ‘precision medicine’ (ESF 2012;
Topol 2012; Obama 2015). As a nexus where these
developments come together we find the emerging field of
systems medicine (see Table 1). Systems medicine is the
medical application of systems biology, a 15-year old
merger of molecular biology, mathematical modelling and
systems theory (i.e. principles describing organized
wholes) (O’Malley and Dupre´ 2005; De Backer et al. 2010;
Bousquet et al. 2011; Green 2014). Systems medicine is
often promoted as ‘P4 medicine’ (predictive, preventive,
personalized and participatory). We will call it ‘P4 systems
medicine’ (‘P4SM’).
Crucially for this contribution, P4SM is associated with
promises of a ‘paradigm change’ explained by the four Ps
in ‘P4 medicine’ (Hood et al. 2012; Kirschner et al. 2013).
Firstly, it promises a shift from a population-based ‘one-
size-fits-all’ medicine to a ‘personalized (or ‘precision’)
medicine’, which can account for the factors that define
each particular individual (Duffy 2015). As shown in a
recent textbook of personalized medicine, systems medi-
cine overlaps with, and is having an increasing impact on,
this wider concept and translational biomedical research in
general (Jain 2015). Secondly, as a form of personalized
medicine, it places particularly strong emphasis on shifting
medicine from a focus on established disease to a
prospective and proactive practice which focuses on pre-
dictive assessments of future health in order to facilitate
disease prevention and optimization of health or wellness
(‘health’ and ‘wellness’ are used synonymously here)
(Diaz et al. 2013; Flores et al. 2013; Kirschner et al. 2013).
Thirdly, according to its participatory aspect, it is promised
to enable patients to shift to the role of agents driving the
revolution.
Most importantly for our argument, P4SM is promised
to achieve all this through a fourth change: A shift in
biomedicine from a ‘reductionist’ towards a ‘holistic’ (or
‘integrative’1) approach, most vividly described by Van-
damme et al. (2013):
In the medical practice, especially in that of the
general practitioner, a more holistic, systems
approach has always been used. The practitioner is
confronted with the patient as a whole, and focuses
on their individual needs and concerns. Every
physician knows that each patient is different, that
there is a need for a personalization of the medical
treatment that they provide. He or she constantly has
to try to integrate data on the emotional state of the
patient, different comorbidities, environmental fac-
tors, family history, etc. In other words, physicians
deal with a lot of non-linear, multidimensional
information, while the medical science they need to
use to make decisions provides them with tools to
make linear, reductionist decisions. There is an
overall theme of ‘one disease, one risk factor, one
target’ with a lack of dynamic information. In the
coming decade, systems medicine aims to provide the
tools to take into account the complexity of the
human body and disease in the everyday medical
practice.
Such promises of holism may seem liberating to the
humanistically minded medical generalist focusing on the
Table 1 P4 systems medicine (predictive, preventive, personalized, participatory)
As shown by a PubMed search using the phrase ‘systems medicine’, this emerging biomedical concept is in rapid growth. For the year 2008
there were seven hits. By November 2015 there were approximately 400 hits for that year
Research projects: The Institute for Systems biology (ISB) recently launched the first phase (‘The Hundred Person Wellness Project’) of its
‘100 K Wellness Project’. This is the first ‘real life’ clinical trial using P4SM principles. It is planned to involve quantification of a large
number of parameters in 100,000 well people (Hood and Price 2014). In Europe the ‘Virtual Physiological Human’ and ‘Digital Patient’ are
central research projects (Diaz et al. 2013; Hunter et al. 2013)
Clinical reality: P4SM is associated with concrete changes to clinical reality as highlighted in the quantified self-movement. Here individuals
employ new technologies, for example genome sequencing and so-called ‘eHealth’, ‘mHealth’ or lifelogging tools (notably smart-phones)
to continuously track their bodily functioning (Wolf 2009; Lupton 2014; Smarr 2012)
Institutions and companies: P4SM is associated with a range of research institutions in the USA, Europe and Asia. Systems medicine has
gained support from the EU and European Commission, which have funded the ‘Coordinating Action Systems Medicine’ (CASyM)
initiative to promote the implementation of systems medicine in Europe, as well as the Virtual Physiological Human and Digital Patient
projects (Kirschner et al. 2013; Diaz et al. 2013; Hunter et al. 2013). In the USA, P4SM is strongly linked to the Institute for Systems
Biology (ISB), the P4 medicine Institute (P4MI), the associated novel company Arivale. The latter has started to deliver actual health
services. Another central US institution is the Harvard Medical School in Boston. In Europe, examples of central institutions are the
European Institute for Systems Biology and Medicine (EISBM) in France, the Luxembourg Centre for Systems Biomedicine (LCSB), The
University of Rostock, Germany and University College Dublin, Ireland. In Asia, there are institutions in India, Singapore and China,
notably the Center for Systems Biomedicine in Shanghai
1 In systems biology the term ‘integrative’ may be used interchange-
ably with ‘holistic’. ‘Integrative biology’ is a synonym for ‘systems
biology’ and the moniker ‘integrative healthcare’ may overlap with
‘systems medicine’ although it is also used in alternative medicine
(Jain 2015).
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health of the patient as a whole. However, at the same time,
P4SM is evidently based on a technoscientific perspective2
that has often been at odds with such holism. As Galas and
Hood (2009) state: ‘Technology and new scientific strate-
gies have always been the drivers of revolutions and this is
certainly the case for P4 medicine’.
Our perspective
The authors of this paper write from the perspective of
academic general practice, specifically a Nordic welfare
state where primary health care is the organizational
foundation. As the point of entry to medical care, it is
specifically concerned with sustainable and responsible
management of the health of whole persons over time
(Getz 2006). The reason why we undertake an analysis of
P4SM is that it explicitly aims to revolutionize the way
primary care is provided, promising to tackle a range of its
challenges, including waste and iatrogenic harm. And
while some of its proponents have stated that academic
medicine should ‘lead, follow or get out of the way’
(Snyderman and Yoediono 2008) as P4SM advances, we
take a critical perspective.
Aim and material
In light of the above, we aim to analyze the concept of
holism in P4 systems medicine, both with regard to its
methods and conceptualization of health and disease. We
do not pretend to assess whether this is a ‘true’ holism or
not, but describe its contents as presented in our material
and some of its implications.
As our material we have selected a set of 40 publications
comprehensively outlining P4SM as it stands today. Our
scope is specific for P4SM, but we do see our analysis as
relevant for understanding key developments in personal-
ized medicine and international healthcare. For more on
our material and scope, see endnotes.3,4
Outline of the argument
Our main argument will be that P4SM aspires to make
medicine holistic, yet does not entail holism as understood in
what has been called humanistic medicine, a stream of med-
ical thought and practice which focuses on the functioning,
subjective experience and values of patients as whole persons,
and which is frequently associated with an anti-medicalization
2 In this article the term ‘technoscientific’ is used broadly to refer to
any phenomenon that is at once scientific and strongly linked to
technology.
3 This article is part of a larger project investigating P4SM as a
proposed framework for primary care, and as such it is based on a
thorough research into the subject matter and underlying philosoph-
ical issues involving many literature searches. To delineate a
suitable and transparent material for this analysis, we performed the
following PubMed search: ‘‘‘systems medicine’’ OR ‘‘systems
biomedicine’’ OR ‘‘P4 medicine’’ OR ‘‘4P medicine’’’. Last per-
formed 2015-11-23 this search yielded 1623 hits. We focused on
identifying comprehensive, theoretical publications outlining P4SM
that are broad in scope and especially relevant for understanding
P4SM as a framework for primary care. We excluded shorter
publications (e.g. editorials) and publications focusing on particular
medical problems or specialities. We thereby selected 31 publica-
tions, the oldest from 2008. We see this material as reflecting the
Footnote 3 continued
emerging field of P4SM well. As described by other authors, systems
biology may be divided in different schools (O’Malley and Dupre´
2005; De Backer et al. 2010; Thomas 2007). The dominant ‘‘prag-
matic’’ or ‘‘molecular’’ school is rooted in functional genomics and
has traditionally sought network-based explanations at the cellular
level using high-throughput ‘omics’ data. There is also a school
rooted in traditional physiology, which is more focused on models
connecting all biological levels. A ‘systems-theoretical’ school
describes researchers that focus strongly on systems theory principles.
These schools are now merging and all are reflected in our material.
However, it suitably mostly reflects the dominant school. The most
influential research environment here is located at The Institute for
systems biology (ISB) in Seattle, USA. Its leading figure, Leroy
Hood, is represented in 10 of the 31 initial publications. Seeing its
‘Hundred Person Wellness Project’ (see Table 1) as especially rele-
vant for our article, we searched the ISB’s list of publications and
annual reports at www.systemsbiology.org and identified 5 additional
publications. Based on our research (reading of reference lists etc.) we
also identified and included an early online document, a European
‘Roadmap to Systems medicine’, a European ‘Digital Patient Road-
map’ as well as a strategy publication for the Virtual physiological
human (Hood and Galas 2008; Kirschner et al. 2013; Hunter et al.
2013; Diaz et al. 2013). The latter two are representative of the
‘physiological’ school of systems medicine. In sum, we included 40
publications, all identified in our reference list.
4 P4SM cannot be seen as representative of biomedicine at large.
However, it is relevant for understanding of broad developments in
international healthcare. Recent remarks made by US president
Barack Obama announcing the Precision Medicine Initiative may
serve as an example (Obama 2015): ‘‘The (…) human genome (…)
today (…) costs less than $2000. Wearable electronics make it easier
than ever to record vital signs (…) And more powerful computers
help us analyze data faster than ever before. So if we combine all
these emerging technologies, if we focus them and make sure that the
connections are made (…) the possibilities are boundless.’ Obama
also emphasised participatory medicine (‘…we want every American
ultimately to be able to securely access and analyze their own health
data, so that they can make the best decisions for themselves and for
their families’). As another example, British Secretary of Health,
James Hunt, recently declared: ‘If you talk to technology gurus in
California (…) They say ‘‘You can get three hundred thousand
biomarkers from a single drop of blood, so why would you depend on
a human brain to calculate what that means when a computer can do
it for you? (…) I think it’s really important that we’re ready in the
NHS to harness the power of data to give us more accurate diagnoses
(…) What this will mean, is we can identify problems before they’re
symptomatic and therefore have a much better chance of tackling
them’ (Matthews-King 2015). These comments are related to the
ideas of P4SM. Moreover, one may note that professor Eric Topol,
author of the ‘The Creative Destruction of medicine’, is in the
scientific advisory board at the P4SM company Arivale (see Table 1).
P4SM also influences US academic medicine (Snyderman and
Yoediono 2008).
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stance (Engel 1977; Marcum 2008; McWhinney and Freeman
2009; Cassell 2013; Miles 2013). Contrary to this position, we
observe how P4SM represents a technoscientific holism
resulting from an altered, more all-encompassing technologi-
cal gaze on human life and related changes in biomedicine’s
methods and philosophy. We then argue that this form of
holism points towards an expanded form of medicalization,
which we call holistic medicalization: Each person’s whole
dynamic life process is defined in biomedical, technoscientific
terms as controllable and underlain a regime of control in
terms of monitoring, quantification, prediction, risk profiling,
early diagnosis, therapy, prevention and optimization that is
all-encompassing. By ‘all-encompassing’ (which here corre-
sponds to the term ‘holistic’) we mean multi-dimensional,
continual throughout life as well as directed at controlling all
types of functioning, primarily healthy life.
We do not by this pretend to discover an entirely new
development. Rather, we argue that this expanded medicaliza-
tion can be seen as the hitherto most concrete and comprehen-
sive materialization of a broader trend, which has previously
been described by several theorists and concepts. We will
especially rely on three of these: biohealth, biomedicalization
and biopolitics (Rose 2007; Clarke et al. 2010; Downing 2011).
From our generalist point of view we see these concepts as
closely related and refer to the historical development that they
together describe as ‘themedicalization of health and life itself’.
We here define medicalization very generally as the process by
which aspects of human life come to be defined inmedical terms
and underlain medical control (Conrad 2007). We do not see
this process as driven solely by medicine, but by many agents.
In the following, we will detail the above exposition in three
parts. (1) In the first part, consisting of the sections ‘A
technoscientific holism’ and ‘Health in technoscientific hol-
ism’, we show how the holism of P4SM arises from an inter-
action between theoretical and technological circumstances
and specify how it defines health, disease and ‘life itself’. With
regard to our argument, the main picture that emerges is that—
however complex—these phenomena are rendered potentially
knowable and controllable by biomedicine. (2) In the second
part, consisting of the sections ‘Holistic medicalization’,
‘Holistic medicalization in practice’ and ‘Participatory med-
icalization’ we then spell out how this technoscientific holism
points towards a holistic medicalization. (3) We then discuss
implicated ‘Potential waste and harm’.
A technoscientific holism
A ‘holistic’ solution for biocomplexity
Aiming to analyze the meaning of ‘holism’ in P4 systems
medicine, we will first explicate the historical context in
which systems biologists use this term. In large part this is
to contrast their approach to a personalized medicine based
on the methods of molecular biology (Calvert and Fujimura
2009).
During the twentieth century there was always a
stream of thought in biology stressing that living organ-
isms are more than the sum of their parts and should be
studied as integrated systems or wholes (Gilbert and
Sarkar 2000). However, as tools for the scientific,
empirical study of such wholes were largely unavailable,
this holism was sidelined by the ‘divide and conquer’
strategy of molecular biology. Molecular biology can be
said to have been ‘reductionist’ in that it was limited to
focusing on one or a few, isolated bodily parts and rel-
atively simple or linear causal relationships between
parts (especially DNA) and the whole (health and dis-
ease). However, some 15 years after the sequencing of
the human genome—molecular biology’s flagship pro-
ject, culminating around the year 2000—this view is in
crisis. Increasing empirical evidence has underscored that
this genotype–phenotype relationship is more complex or
non-linear than assumed (Woese 2004; Keller 2005).
Systems medicine, which partly springs out of the human
genome project and functional genomics, reflects this
realization: In order to understand, predict—and thus
control—the complexity of health and disease, one must
study these phenomena in terms of integrated, dynamic,
complex systems (Thomas 2007; Auffray et al. 2009;
Antony et al. 2012; Wang et al. 2015). Systems medicine
thus offers a solution to the challenge of biocomplexity
that its proponents describe as ‘holistic’. Quote systems
biologist Leroy Hood (2008):
The dominant challenge for all the scientific and
engineering disciplines in the twenty-first century
will be complexity, and biology is now in a unique
position to solve the deep problems arising from its
complexity and to begin to apply this knowledge to
the most challenging issues of humankind. Biology
will use systems approaches (holistic, as opposed to
atomistic) and powerful new measurement and visu-
alization technologies, as well as the new computa-
tional and mathematical tools that are emerging in the
aftermath of the human genome project and the
emergence of systems biology.
As indicated by this statement, a crucial enabling factor
behind the holism of P4SM is new technology. These tools
constrain the questions it may ask empirically. Crucially
for our argument they also enable continued hope that,
however complex, human wholes may yet be defined and
controlled by science.
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A holistic method
Hood and Flores (2012) summarize the method of P4SM as
follows:
Ironically many people use the term ‘genomic med-
icine’ to denote the medicine of the future—yet in
principle genomic medicine is one-dimensional in
nature—only encompassing nucleic acid information.
Systems medicine, by contrast, is holistic and utilizes
all types of biological information—DNA, RNA,
protein, metabolites, small molecules, interactions,
cells, organs, individuals, social networks and exter-
nal environmental signals—integrating them so as to
lead to predictive and actionable models for health
and disease.
As exemplified by the above quotation, proponents of
P4SM use the term ‘holistic’ in two related ways with
regard to their methods and tools:
1. ‘Holistic measurements’: Firstly, the word ‘holistic’
comes to mean the use of new technologies to gather
big data about each particular person that are as all-
encompassing or ‘global’ as possible (De Backer et al.
2010; Diaz et al. 2013; Flores et al. 2013). These
measurements in turn have two aspects that will
reappear in what we call holistic medicalization:
(a) Spatially, the measurements are multi-dimensional
in that they pertain to all levels of biological organi-
zation. (b) Temporally, the technologies enable re-
peated or continual measurements through time that
represent the dynamism of health and disease in a way
that is new to biomedicine (Emmert-Streib and
Dehmer 2013). The envisioned end result is a dynamic
data cloud that reflects the whole life process in all four
dimensions, consisting of ‘billions of data points’
(Bousquet et al. 2011).
All conceivable technologies could potentially con-
tribute to these measurements. However, the core data
are molecular and enabled by new, high-throughput
‘omics’ technologies that generate whole ‘parts lists’
of molecules (e.g. genomics, proteomics, transcrip-
tomics, metabolomics, epigenomics) (Ayers and Day
2015; Wang et al. 2015). Additionally, a massive
phenotyping (’phenomics’) and mapping of environ-
mental exposures is undertaken using for example
microbiomics of bacterial flora, imaging, electronic
health records, home telemonitoring, social media and
various sensor technologies (implanted or external)
coupled to smart-phones to monitor a range of bodily
functions (Diaz et al. 2013).
2. ‘Holistic (integrative) models’: Secondly, the ‘holistic’
method involves using novel computer technologies to
interpret the initially fragmented ‘holistic data’. One
set of methods in this sense-making process comes
from bioinformatics, but the key objective of systems
medicine is to use mathematical modelling to integrate
the data in what is called ‘holistic multi-scale models’
(Duffy 2015, see also Clermont et al. 2009; Wolken-
hauer et al. 2014). According to Flores et al. (2013),
‘These models decipher biological complexity by
showing how all elements in biological systems
interact with each other to produce health and disease
states’. A main goal is to study the way bodily systems
transition between health and disease and thus generate
the mechanistic explanations and predictive power
needed to establish control of complex wholes (Hood
and Price 2014). Crucially, the technologies of P4SM
now also allow monitoring of the phases of life in
which people are healthy, enabling nothing less than an
attempt to quantify health (Hood 2013). This may be
seen as an aspect of systems biology’s wider aim of
calculating life, as expressed by Boogerd et al. (2007,
chapter 14): ‘With systems biology, life, first at the
simplest level (…) and perhaps ultimately at the level
of intelligent human beings will become calculable’.
Perhaps the ultimate expression of the goal of quan-
tifying the whole life process is the European Digital
Patient project, which aims to create a ‘medical
avatar’ of each citizen to be compared to a generic
‘virtual physiological human’ (Hunter et al. 2013).
According to its roadmap, ‘Avatar literally means
embodiment or manifestation and is a 4D personalised
representation of individual patients’ that can ‘provide
individualised (person-specific) future projections,
systemic predictions based on mechanistic understand-
ing of the disease process in an integrative and holistic
view’ (Diaz et al. 2013, p. 60 and p. 13).
Holistic theory
On the theoretical level, the holism of P4SM corresponds
to the idea of life as a complex system, which by definition
refers to some kind of integrated whole. However, how a
‘system’ (and the emergent properties that arise from its
dynamics) are understood may in turn vary, making dif-
ferent ‘holisms’ possible (O’Malley and Dupre´ 2005).
Systems theory could potentially be used to argue that
human health is so complex that it is hard to predict and
control5 (Bishop 2011). However, in practice, the models
5 Here it seems pertinent to note that, in the past, representatives of
humanistic medicine have also employed systems theory in their
holistic conceptions of health, but then mainly to bolster an emphasis
on the social interactions and personal experience of human wholes
(Engel 1977; McWhinney and Freeman 2009; Sturmberg 2013).
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that define P4SM theory seem mostly to be chosen with the
aim of controlling the workings of wholes. As Tian et al.
(2012) clearly state: ‘Models may be descriptive, graphical
or mathematical as dictated by the amount of available
data, but they must be predictive. For medical use, pre-
dictions made must be actionable and useful for treating
patients’.
For this purpose models are mainly adopted from
mathematics, physics, computer science and engineering
(Antony et al. 2012; Hunter et al. 2013; Wolkenhauer et al.
2013; Wang et al. 2015). Moreno et al. (2011) describe
this systems theory or ‘network theory’, as…
…the set of mathematical and computer simulation
models and tools that have been developed to study
network architectures and dynamics. Although there
is no unified branch or corpus of mathematics that
constitutes network theory, there exists however an
increasingly indispensable ‘tool-kit’ of methods and
disciplines that merge into what we might call net-
work theory: this ranges from dynamical systems
theory to network topology, from random boolean
network models to coupled oscillators. The study of
networks with strongly and recurrently interacting
components allowed scientists to deal with holistic
systems, showing that, despite their variety, they
share certain generic properties.
In sum, we see a radically expanded approach to studying
human beings.
Health in technoscientific holism
This technoscientific holism alters biomedicine’s concep-
tion of health and disease (‘the biomedical model’) in
several ways:
Health as multi-level
In P4SM technology and theory now allow health and dis-
ease to be characterized as multi-level phenomena. The
whole human organism is portrayed as a highly non-linear
system, often as a network of networks (Hood et al. 2012;
Vandamme et al. 2013) (see Figs. 1, 2). P4SM thus takes
biomedicine from conceptualizing health and disease as
resulting from linear relationships between parts and wholes
(a ‘gene-centric’ view) to a multi-causal, non-linear ‘net-
work-centric’ view (Younesi and Hofmann-Apitius 2013).
Health as process
Relatedly, P4SM’s longitudinal monitoring and theories of
system dynamics promote a process view of health, taking
biomedicine along an epistemological ‘epigenetic turn’
(Nicolosi and Ruivenkamp 2012). The development of
each individual is conceptualized as the process of gene–
environment interaction (GxE), where the ‘environment’
includes ‘psychosocial’ factors. Crucially, these interac-
tions may be seen as genetic and environmental informa-
tion that is integrated and encoded in the dynamic
networks. To some systems biologists, biomedicine then
becomes the informational science that deciphers this
information (Bousquet et al. 2011).
Health and disease as system states
This leads us to the P4SM definition of health and disease.
Both phenomena are conceptualized as dynamic, functional
states of the system that emerge through the GxE process
(del Sol et al. 2010; Bousquet et al. 2011). These states
may be seen as emergent properties of the whole, and
health may also be conceptualized as robustness (the
ability to maintain system integrity despite perturbations)
(Federoff and Gostin 2009; Antony et al. 2012). In this
picture, health and disease may also be seen as different
aspects of a single continuum of potential network states in
space and time (Hood and Flores 2012). Diseases may be
defined in terms of abnormal and health in minimal terms
as normal network states (del Sol et al. 2010) (see Fig. 2).
The totality of possible states a system can be in is defined
as a ‘state space’, and health and disease as different tra-
jectories of states in this space (Antony et al. 2012).
Health as individual specific
As the interactions between environmental and genetic
factors are quite unique in each particular case, health and
disease are underscored as individual-specific phenomena
in P4SM. Technologies describing each individual in detail
support this view. According to Bousquet et al. (2011),
non-communicable diseases ‘should be considered as the
expression of a continuum or common group of diseases
with intertwined gene–environment, socio-economic inter-
actions and co-morbidities that lead to complex phenotypes
specific for each individual.’
A mechanistic and predictable health
So far, we have described the factors that make the P4SM
conception of health ‘holistic’. What qualifies this holism
as ‘technoscientific’?
Systems biology is the site of deep epistemological and
ontological discussions, notably about causation and pre-
dictability in living organisms (Wolkenhauer et al. 2013;
Wolkenhauer and Green 2013; Boissel et al. 2015). How-
ever, mainstream P4SM seems to adhere to the machine
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metaphor of life. Mechanistic explanation and predictive
power are main goals. Its mathematical models are often
mechanistic and deterministic, and health and disease are
widely defined as mechanistically explainable.6 Most sig-
nificantly for our argument, the whole and its health are
defined as potentially quantifiable (Antony et al. 2012;
Diaz et al. 2013; Flores et al. 2013; Kirschner et al. 2013;
Cesario et al. 2014b; Wang et al. 2015). In P4SM—as in
systems biology—the concept of holism seems often to go
hand in hand with the assumption that the emergent
properties of the whole (i.e. health or illness) can be
mechanistically explained and scientifically predicted
(Boogerd et al. 2007). P4SM attempts to describe the
unfolding process in mechanistic detail as something con-
crete (Boenink 2009). Consider Fig. 2: Represented in a
technologically generated virtual reality, it is as if health
and disease are objective and there. And while the meta-
phor of the genome as the ‘book of life’ may be obsolete,
and the road towards unravelling the actual mechanistic
Fig. 1 The human being as a
dynamic network of networks.
In systems medicine the human
organism is envisioned as a
system of systems or network of





portrayed as giving rise to and
embedding each other. At all
levels the network of networks
is seen as a dynamic or four-
dimensional process (as
opposed to a static thing)
(Copyright: The Institute for
Systems Biology, used with
permission)
6 A radio analogy of life has been frequently used in systems biology.
Leroy Hood brings it to systems medicine: ‘A holistic, integrative or
systems approach can be explained by a simple analogy. In order to
understand how a radio converts electromagnetic waves into sound
waves, the first step would be to compile a list of its components. Then
the components would be studied individually to ascertain what each
component does independently. After understanding the individual
parts, the next step would be to assemble the parts into circuits and
then understand individually and collectively how the circuits convert
radio waves into sound waves’ (Hood 2013).
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workings of the body long, the whole life story may still be
portrayed as information that biomedicine can decipher
(Bousquet et al. 2011).
The most striking example of the idea of life as calcu-
lable is a programmatic proposition by leading figures to
‘generate a multiparameter metric for wellness—by
employing data from individuals exhibiting wellness over
an extended period of time. It will reflect both the psy-
chological and physiological aspects of wellness’ (Hood
et al. 2015a). According to Cesario et al. (2014b), ‘Well-
ness as a status to be achieved and maintained in our lives,
getting longer and hopefully healtier, is the new and
comprehensive declination of ‘‘health’’ itself, leading the
shaping of research and research policy in the health
domain worldwide.’ Flores et al. (2013) even state that
P4SM models will be ‘increasingly powerful predictors of
each individual’s personal experience of health and dis-
ease. These models not only demystify disease, they also
quantify what it means to be healthy’.
All in all, the picture that emerges in P4SM is an effort
to make medicine a harder science (Calvert and Fujimura
2009). It is a holism that entails a strong form of natural-
ism, which, in a medical context, is the view that health and
disease are knowable through the methods of natural sci-
ence (Marcum 2008).
A controllable health
This naturalism is philosophically attractive: It appears to
render not only disease but also states of wellness poten-
tially controllable. Quote Hood and Flores (2012): ‘Sys-
tems (P4) medicine is now pioneering something that never
existed before—actionable understandings of disease and
wellness as a continuum of network states, unique in time
and space to each individual human being’.
On the theoretical level, this is the essence of techno-
scientific holism: Although the whole life process of each
individual is defined as complex, this whole—and the
whole continuum of health and disease states it may be
in—is defined as potentially quantifiable, predictable and
actionable. ‘Actionable’ here means controllable. And
defining an aspect of life in medical terms as controllable is
a key step in the process of medicalization, leading us to
the second main part of our argument (Conrad 2007).
Holistic medicalization
We will now spell out how we see technoscientific holism
as pointing towards a holistic medicalization. We begin by
outlining the wider trend in which we place this develop-
ment: ‘the medicalization of health and life itself’.
The medicalization of health and life itself
Somewhat simplified, we can say that biomedicine, with its
technoscientific approach, has traditionally been limited to
a reactive and reductionist focus on parts-associated dis-
ease. As a corollary, biomedically rooted medicalization
has mostly consisted in labelling aspects of life as diseases.
Healthy life has largely been dismissed as the absence of
disease (Hofmann 2002; Marcum 2008). In other words,
our path towards health itself has not been medicalized by
technoscientific biomedicine like our approach to suffering.
The biomedical focus on disease has left an open space
for attention to wholeness, health and human life-stories.
Alternative medicine aside, this space has most often been
filled by the holism of what has been called humanistic
medicine (Marcum 2008). Such holism has been most
strongly associated with medical generalism and concepts
such as biopsychosocial, patient-centered, person-centered
and narrative medicine (Engel 1977; McWhinney and
Freeman 2009; Cassell 2013; Miles 2013). Traditionally, it
is also this stream of thought that has advocated a shift in
focus from disease towards the concept of health or well-
being (Cassell 2013). Such holism has then typically linked
Fig. 2 Disease and health as network states. One common way to
represent systems or networks in PMSM is as graphs, where
interacting units (e.g. molecules) are nodes and their interactions
edges. According to one publication, this figure presents ‘A schematic
view of a normal (left) and a disease-perturbed network (right). Both
node points (colored balls) and edges (lines attaching the balls)
change in disease as indicated by changing colors indicative of
changing levels and the disappearance of an edge. The nodes and
edges change dynamically with disease progression’ (Hood 2013).
(Copyright: The Institute for Systems Biology, used with permission).
(Color figure online)
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health to capacities of the whole person as a conscious
agent and tended to define these capacities as beyond exact
scientific description. Instead, health has been tied to the
most complex aspects of human life and thought to be a
subjective and culturally value-laden (normative) phe-
nomenon (Boenink 2009; Sturmberg 2013). Health has
thereby been defined in positive terms as something more
and other than the absence of disease that may even be
compatible with disease. Critically, this form of holism has
been associated with a certain tolerance towards disease
and death and skepticism towards medicalization. Health
has simply not been considered technoscientifically
actionable like disease (Gadamer 1996; Hofmann 2002).
This traditional state of affairs is undergoing deep
change through ‘the medicalization of health and life itself’
as described by three concepts: biohealth, biomedicaliza-
tion and biopolitics (Rose 2007; Clarke et al. 2010;
Downing 2011). With P4SM the undercurrents that these
authors have pointed at seem to surface as a comprehensive
framework.
Biohealth, biomedicalization, biopolitics
Primary care physician and philosopher Raymond Down-
ing describes his concept of biohealth as follows:
We are now in a phase beyond medicalization when
even health—the ‘‘opposite’’ of medicine’s focus,
disease—has become medicalized. Biomedicine,
assuming it knows what health is, imposes that
understanding on everyone. Medicine used to claim
authority over the cracks and interruptions in life;
now it claims authority over all of life (Downing
2011, p. 2).
According to Downing systems thinking inherently leads to
an expansion of medicalization as it induces us to capture
all aspects of a phenomenon (e.g. a person’s life). And: ‘In
describing or designing a system, we not only want to
include every part, we also want to make each part captive,
to control it’ (Downing 2011, p. 70). Medicalization may in
fact be seen as an inbuilt potential of all holism as holism
is, by definition, all-encompassing.7
Similarly to biohealth, the concept of ‘biomedicaliza-
tion’, developed by sociologist Adele Clarke and cowork-
ers, describes an expansion of medicalization: A broad,
multi-faceted trend towards not only defining and con-
trolling evermore aspects of life as disease, but increas-
ingly also towards health optimization and ‘The extension
of medical jurisdiction over health itself (in addition to
illness, disease and injury)’ (Clarke et al. 2010, p. 48).
Biopolitics (the term ‘politics’ connoting ‘power’) is a
perspective developed by sociologist Nikolas Rose, build-
ing on philosopher Michel Foucault’s concept of biopower.
It refers to a management of life, which…
…is neither delimited by the poles of illness and
health, nor focused on eliminating pathology to pro-
tect the destiny of the nation. Rather, it is concerned
with our growing capacities to control, manage,
engineer, reshape, and modulate the very vital
capacities of human beings as living creatures. It is, I
suggest a politics of ‘‘life itself’’ (Rose 2007, p. 3).
Holistic medicalization in theory
How does medicalization become ‘holistic’ on a theoretical
level in P4SM; how does it define aspects of life in medical
terms? Although this is not the place to enter the vast
debates on health and holism, we first want to note that the
concepts of holism, wholes, wholeness and health are ety-
mologically and philosophically related. The very foun-
dation of these ideas is now changing. ‘Biohealth’,
Downing remarks is ‘the sort of health and wholeness that
results from applying the biological sciences’ (Downing
2011, p. 6).
We will argue that the ‘holistic medicalization’ of P4SM
is envisioned as the most advanced and systematic example
to date of what Downing is pointing at. As we hope to have
shown, the very idea of holism is redefined in P4SM and
given a technoscientific meaning. In other words, the
aspect of life that is defined in medical terms is wholeness
itself. When the life process is understood in terms of
dynamic wholes, but these wholes are defined as quantifi-
able and controllable through technoscientific means,
biomedicalization becomes holistic on a theoretical level.
Holistic medicalization does not primarily entail that
aspects of life are defined as new diseases. Rather, it puts
wholeness and health itself under medical jurisdiction,
pointing toward a situation in which ‘life itself’ is
controlled.
This is highlighted by the idea that one can provide a
multi-level metric for wellness, with not only ‘physiologi-
cal’, but also ‘psychological’ parameters by which to orient
one’s way of life. According to this view, health is ‘a
concept that to date has been defined in vague and
7 Downing also directs the criticism that systems thinking leads to
medicalization towards the use of systems theory in Engel’s
biopsychosocial model and patient-centered medicine (Engel 1977;
McWhinney and Freeman 2009). However, we see important
differences between this and P4SM. The adoption of systems theory
in what has been called humanistic medicine has been intended as a
metaphorical tool when one competent clinician seeks to ‘model’
other persons in order to avoid reducing their problems to molecules.
In P4SM, such ‘human modelling’ would be replaced mathematical
modelling and the doctor-patient relationship with a computer
interface and computational decision support.
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ambiguous terms’ (Hood et al. 2015a). Through techno-
scientific holism this ‘vagueness’ is now to come to an end.
As scientists at the Institute for Systems Biology state,
‘wellness—and how to enhance it and extend it—has not
been studied very thoroughly by scientists. ISB proposes to
change this by taking a systems-approach to understanding
wellness—and thereby make it scientific’ (Hood et al.
2015b). This idea of a ‘scientific wellness’ becomes even
more radical as the disease-health continuum should—at
least according to Hood and coauthors—not be envisioned
as stopping at normality, but as additionally involving a
positive ‘wellness space’ of network states that is more and
other than absence of disease (Flores et al. 2013). How-
ever, in sharp contrast to humanistic medical holism, see
e.g. Cassell (2013), this positively defined health is por-
trayed as something that can be defined through techno-
scientific means.
From molecularization towards synthesis
An important claim in the concepts of biomedicalization
and biopolitics is that health and ‘life itself’ have
increasingly become molecularized (Rose 2007; Clarke
et al. 2010). Rose remarks that ‘It is now at the molecular
level that human life is understood, at the molecular level
that its processes can be anatomized, and at the molecular
level that life can now be engineered’ (Rose 2007, p. 4).
Does the holism of P4SM also involve such molecular-
ization? The answer is ‘yes, but…’.
Systems biology is technologically strongly focused on
molecular parts (De Backer et al. 2010). As a corollary the
wholes that P4SM models are also mostly molecular
wholes (Mardinoglu and Nielsen 2012; Emmert-Streib and
Dehmer 2013; Ayers and Day 2015; Wang et al. 2015). As
illustrated by talk of ‘molecular level (…) processes that
define and drive physiology’ and provide ‘deep under-
standing of causality’ (Flores et al. 2013), the molecular is
central to its philosophy of causation and epistemology.
The overall aim is to connect the whole to its parts, and the
whole seems mostly to be defined in molecular terms. Such
a molecular holism is a contradiction in terms and better
understood as a form of reductionism (De Backer et al.
2010).
However, at the same time, P4SM involves profound
discussions about the organizing principles by which
wholes govern parts (Antony et al. 2012; Wolkenhauer
et al. 2013; Wolkenhauer and Green 2013). Its deepest
theoretical contribution may be that it slowly moves bio-
medicine from a one-dimensional molecular focus towards
a view where no level is causally or epistemologically
privileged (Noble 2007; O’Malley and Dupre´ 2005). Quote
Boissel et al. (2015): ‘The solution must include multilevel
interactions in an integrative approach. Thus, systems
medicine should go beyond the realm of the intracellular
layer to integrate upper physiological layers, including all
time and complexity level components’.
This seems partly at odds with Rose’s view of molec-
ularization as an epistemological change away from the
nineteenth century view of the body as a ‘system of sys-
tems’ (Rose 2007, p. 43). P4SM represents precisely a
move towards such a view. Our key point in this article is
that this also changes medicalization. As new tools now
seem to allow synthesis, the process of medicalization also
moves beyond molecularization to a synthetic phase. The
endgame of medicalization will result from trying to piece
all bodily pieces together to define and control life in toto.
Defining the limits of medicalization
In one publication, Juengst et al. (2012) voiced concerns
over potential problems with personalized medicine—for
example pursuit of human enhancement. P4SM proponents
responded by pointing precisely to their holism:
For the most part, these concerns are alleviated by
eliminating the undue focus on genetics (…), the
scientific and technological foundation of P4 health-
care rests on systems approaches to big data on many
different dimensions of health, not just genomic
factors. Systems approaches are powerful precisely
because they integrate all of these data to delineate
how environmental and genetic factors interact to
shape individual experiences of health and disease
(Flores et al. 2013).
However, to the extent that medicalization poses problems,
this argument offers cold comfort. For the more holistic
P4SM will become, while at the same time defining ‘the
whole’ as technoscientifically actionable, the more medi-
calizing it may get. The perfect endgame, a technologically
based mirror image—or ‘avatar’—of each individual that
enables the prediction and control of all health aspects—
will logically also involve total medicalization. We con-
jecture that systems medicine will define the future limits
of medicalization. As the major rate-limiting hindrance to
medicalization is biocomplexity, and P4SM models will
likely define biomedicine’s uttermost efforts to overcome
this complexity, it will also delineate the degree to which
life can be technoscientifically controlled.
Holistic medicalization in practice
What would holistic medicalization of P4SM look like in
practice, if realized? A vision presented in the European
‘Digital Patient’ roadmap is illuminating:
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The vision of a ‘‘digital me’’ that contains all my
health-care information, (…) communicated with all
my wearable and implanted technology to constantly
monitor my health status and informing me, my
family and friends, or my healthcare providers of
alarming events, supporting the collaboration of
various specialists around my complex systemic
diseases, and used with all my data to predict the
future development of my health in order to facilitate
disease prevention and a fully self-aware lifestyle
(Diaz et al. 2013, p. 57).
Firstly, we see that P4SM would still be directed at
managing disease, especially chronic disease that requires
long-term management of life (Cesario et al. 2014a).
However, while disease would still be one focus, health-
care would shift in scope so as to favour the management
of the health and lives of healthy or asymptomatic
people—that is all people. This management would be
both multi-level, continuous throughout the lifecourse and
directed at all types of network states all along the
continuum from overt pathology, via more or less well-
discerned risk profiles, ‘normality’ and into the positive
‘wellness space’ (Diaz et al. 2013; Flores et al. 2013).
The main thrust in P4SM would be prevention involving
risk profiling and early diagnosis in healthy or asymp-
tomatic people (Bousquet et al. 2011). The definition of
health as potentially predictable and controllable may be
key to this ambition:
In the future, we will be able to design drugs to
prevent networks from becoming disease perturbed.
For example, if there is an 80 % change of prostate
cancer at age 50, taking these preventive drugs
beginning at age 35 may reduce disease probability to
2 % (Hood 2008).
In addition to disease management and prevention, P4SM
practice would—at least according to some leading
proponents—not only be directed at disease as something
negative, but optimization of health or wellness as some-
thing positive. Another ‘P’ could thereby be added to ‘P4’:
Promotive medicine. According to Boissel et al. (2015),
‘The optimization of wellness is a key to maximizing human
potential for each individual—improving physiological as
well as psychological performances.’
With regard to such optimization, one key aim is to
elucidate and manipulate the process of ageing, which is
hard to delineate from the process of ‘life itself’ (Hood and
Flores 2012; Bousquet et al. 2014). As an example, the
Digital Patient Roadmap reduces aging to the dominant
risk factor of disease: ‘Ageing is a hurdle to overcome and
its inclusion is personalised models for the Digital Patient
is a challenge that multi-scale models will need to resolve’
(Diaz et al. 2013). Even more profoundly, systems biology
is also the basis of synthetic biology, which aims specifi-
cally to engineer new properties of life (Auffray et al.
2009).
Optimization or enhancement of human capacities is
central to the concepts of biohealth, biomedicalization and
biopolitics (i.e. the’ medicalization of health and life
itself’). According to Rose, ‘The old lines between treat-
ment, correction, and enhancement can no longer be sus-
tained’ (Rose 2007, p. 6). When P4SM becomes
sufficiently efficient in transforming the processes of life,
these borders will blur. In the P4SM visions, prevention
also seems based on optimization, and optimization always
to imply that something is in some way suboptimal. It also
seems clear that the proposed P4SM metrics of health will
involve many of the same (predominantly molecular)
parameters used to define disease (Wang et al. 2010). If so,
the language of health will to a large extent be derived
from the language of disease.
Diagnostics and prognostics
As part of a preventive and health-optimization strategy,
diagnostics and prognostics would as default involve a
multi-level, continuous and individualized monitoring or
screening process (Bousquet et al. 2011). This amounts to
an advanced form of what has been called surveillance
medicine (Armstrong 1995). Although the diagnostic pro-
cess would use information from all levels in a ‘holistic’
fashion, it would be biomarker-based (Mardinoglu and
Nielsen 2012; Younesi and Hofmann-Apitius 2013). And
while previous biomarkers have mostly been single-com-
ponent, future P4SM biomarkers may be ‘network
biomarkers’ (Wang et al. 2015). One aim is to make ‘blood
a window for assessing health and disease’ (Hood and
Flores 2012) by constructing diagnostic technologies that
can regularly assess ‘molecular fingerprints’ reflecting
specific network states (Wang et al. 2010).
Risk is a key concept in the medicalization of health and
‘life itself’ (Clarke et al. 2010; Downing 2011; Rose 2007).
With regard to disease prevention, we conjecture that the
very concepts of risk or susceptibility to disease will
change in P4SM. As the idea of what holds our destiny
changes from static DNA or a few riskfactors to the
workings of the dynamic network, they will become more
multi-factorial and dynamic concepts. The need to account
for all these factors implies a increased focus on risk that is
unprecedented in its all-encompassing scope.
If P4SM would venture into active health optimization,
‘actionable possibilities’ would additionally emerge in
positive wellness space—pointing perhaps towards a radi-
cally new diagnostics of health (Hood and Price 2014).
Preliminary results from the ISB ‘Hundred Person
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Wellness Project’ show how expansive P4SM may become
in labelling well people: ‘So far, after having analyzed just
a few types of data, we’ve found that 100 % of the 100
Pioneers have multiple actionable possibilities’ (Hood
2014). Here, the concept of ‘an actionable’, frequently
used by Hood and collegues, may both be understood as a
relabelling of the traditional concept of risk of disease, but
also as a piece of information that may be useful in
enhancing one’s wellness or performance.
Intervention
Like the diagnostic process, intervention would also turn
into a life-long, dynamic project that would be directed at
tackling all components of the complexity of health,
including potentially the personal (or ‘psychological’) and
social. A large group of P4SM advocates argues that
management of non-communicable disease (NCD)…
…should move towards holistic multi-modal inte-
grated care, and multi-scale, multi-level systems
approaches. (…) Systems medicine aims to tackle all
components of the complexity of NCDs so as to
understand these various phenotypes and hence
enable prevention (Bousquet et al. 2011).
Genes are no longer regarded as destiny. As a corollary,
P4SM emphasises preventive lifestyle interventions (Bous-
quet et al. 2014; Hood 2014). In this regard, what is
considered ‘medical treatment’ might potentially change
and focus more on non-technological intervention. This
may also seem non-medicalizing. However, biomedicine
would still strengthen its grip on what it means to lead a
healthy life, and even lifestyle, living itself, would be
grounded in a continuous, technologically based monitor-
ing of risk-factors.
In practice, operationalizing and modelling complex
personal and social factors is harder and has a much lower
priority in current P4SM research than the molecular level.
Drug development is a main focus: ‘By deciphering which
biological networks are perturbed in diseases, systems
medicine will provide a stream of new drug targets for the
pharmaceutical industry’ (Flores et al. 2013). In accor-
dance with the principles of network theory, pharmaceu-
tical intervention would also change, turning into a process
of control engineering. As the view of what must be con-
trolled changes from linear to non-linear, treatment is also
envisioned as multicausal: ‘A new ‘‘network-centric’’
rather than ‘‘gene-centric’’ approach to choosing drug
targets will employ multiple drugs to ‘‘re-engineer’’ a
disease-perturbed network to make it behave in a more
normal manner’ (Hood and Flores 2012). In other words,
technoscientific holism leads to a complexification of
pharmaceutical treatment and polypharmacy as default.
Participatory medicalization
According to its participatory aspect, P4SM is envisioned
as requiring an expansion of healthcare far beyond the
clinic. Patients, families and communities working in net-
works are expected to drive its realization (Diaz et al. 2013;
Hood and Auffray 2013; Kirschner et al. 2013). As this
aspect defines P4SM, it will also define an aspect of holistic
medicalization. We will call this participatory
medicalization.
Again the novel technologies of P4SM are the enabling
factor. Firstly, they are primarily directed at the individual
body and its subsystems. Correspondingly, both personal
and public health is tied to the individual person, who is
expected to live life to the fullest in symbiosis with the
biomedical tools that provide access to health. The longi-
tudinal cloud of billions of data points gathered for each
individual allows his/her life to be envisioned as a form of
N-of-1 study in which each person is a vital participant in
his or her own ‘holistic’ description (Kirschner et al. 2013;
Hood and Price 2014). This is one hallmark of ‘the medi-
calization of health and life itself’: It is focused on the
individual and health becomes a personal goal and
responsibility (Rose 2007; Clarke et al. 2010;
Downing 2011).
Secondly, the quest for personalized medicine (some-
what paradoxically) requires everyone to participate. To
develop valid predictive power, P4SM needs data from a
population that is as big and diverse as possible in order to
mine the data for regularities, to demarcate health and to
stratify the population:
In order to take into account the full range of bio-
logical complexity and define the range of healthy
behavior, these data need to be obtained for as many
people as possible in the population—ideally every-
one—not just for small test samples (Flores et al.
2013).
This need also explains imperatives for people to share
their data:
We stress that patients must understand that it is their
societal responsibility to make their anonymized data
available to appropriate scientists and physicians so
that the latter can create the predictive medicine of
the future that will transform the health of their
children and grandchildren (Bousquet et al. 2011).
In other words: Participation is a requirement for the
holism of P4SM and the holistic medicalization it implies.
It involves what Rose calls a mode of subjectification…
…through which individuals are brought to work on
themselves, under certain forms of authority, (…) by
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means of practices of the self, in the name of their
own life or health, that of their family or some other
collectivity, or indeed in the name of the life or health
of the population as a whole (Rabinow and Rose
2006).
The participation of each patient consumer in novel social
communities is a vivid example of what Rose’s collabo-
rator, anthropologist Paul Rabinow, terms biosociality
(Rabinow and Rose 2006).
As a pioneering example of the wellness-regime that
P4SM hopes to establish, computer scientist Larry Smarr
has published results from 10 years of self-monitoring
(Smarr 2012; Hood and Price 2014). Smarr employed
multiple tools to measure his genome, blood markers
([100 variables), stool markers, diet, exercise, sleep and
stress, pointing also towards more ‘wholesome’ personal
omics profiling in future self-quantification.
With reference to the quantified self-movement that
Smarr pioneered (Table 1), we may predict that P4SM will
contribute strongly to what Rose calls ‘biological citizen-
ship’ or ‘somatic individuality’, the formation of a kind of
personal identity in which ‘we are increasingly coming to
relate to ourselves as ‘‘somatic’’ individuals (…) who
experience, articulate, judge, and act upon ourselves in
part in the language of biomedicine’ (Rose 2007, p. 26). As
an enabling factor of this development, some technologies
(e.g. tracking devices) or at least their results (e.g. genome
information) are becoming cheaply available to citizens.
Technology is democratized. As a consequence, P4SM is
presented as democratizing and empowering, enabling
people to know themselves and establish self-control (Hood
and Price 2014; Duffy 2015). However, to the extent that
people will gain—or lose—genuine control of their life,
they will do so according to the metrics of P4SM. To be in
a position to define a metric of health according to which
people manage their lives is power, an example of what
Rose calls ‘somatic expertise’ and ethopolitics, the latter
meaning ‘attempts to shape the conduct of human beings
by acting upon their sentiments, beliefs, and values—in
short by acting on their ethics’ through ‘self-techniques by
which human beings should judge and act upon themselves
to make themselves better than they are’ (Rose 2007,
p. 27).
We thus argue that what is most evidently ‘democra-
tized’ in participatory medicine is the ability to self-medi-
calize, and in P4SM more ‘holistically’ than ever. Patients
may become more active, but their goals are still defined by
the agents behind P4SM. It should be noted that the leaders
of the ‘Hundred Person Wellness Project’ project (see
Table 1) recently stated that most of its participants
‘established a new and very personalized baseline for their
own health’ through the research (Hood et al. 2015b).
However, it is unclear at this point how each individual’s
personal baseline of health is thought established (e.g. is it
defined using measures of subjective well-being or
molecular markers?). It is also unclear how population-
based metrics of health and each person’s baseline are to
relate (e.g. which one of them will actually define what
health means in the individual case?).
Potential waste and harm
Control as value and goal
The extent to which health can in practice be given a
meaningful scientific definition and controlled is an open
question. However, one does not have to actually succeed
in controlling human wholes for holistic medicalization to
be realized. One only needs to believe it possible and make
the attempt. As evident in the quantified self-movement,
the values and goals of P4SM are likely to become defining
to identities and actions in healthcare and beyond even
before the framework is supported by empirical evidence
(Lupton 2014; Wolf 2009; Smarr 2012). What are the
values and goals of P4SM? Manifold, but we will state just
one: Control itself. Physiologist Claude Bernard
(1813–1878), who foresaw the application of mathematics
to biology and has been called ‘the first systems biologist’,
can also serve as an historical reference for this ideal
(Noble 2007). While Bernard had sophisticated ideas of
living wholes, he also stated that ‘When an experimenter
succeeds in learning the necessary conditions’ of the
phenomena he is studying, ‘‘he is, in some sense, its mas-
ter; he can predict its course and appearance, he can
promote or prevent it at will’’ (cited in Comfort 2012,
p. 46). Consider also our opening quote by Loeb, who
pioneered the biological engineering ideal so prevalent in
P4SM. We see P4SM as biomedicine’s latest and most all-
encompassing step in pursuing this goal.
Beneficent and harmful medicalization
That said we want to stress that we see nothing inherently
wrong with control or medicalization. Beneficent control is
a key aim of medicine. However, as reflected in the ancient
medical proverb ‘first do no harm’, all medicalization also
comes with caveats (i.e. ‘overmedicalization’ or ‘futile
medicalization’). A full discussion of all caveats implicated
by the holistic medicalization of P4SM is beyond our
scope, but we will point out what we find most
fundamental.
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False positives, overdiagnosis, opportunity cost
Firstly, the number of measurements and continuous (self)-
management of well people will likely increase findings of
uncertain significance, false positive tests, overdiagnosis
and overtreatment (Diamandis 2015). Even if these prob-
lems were nullified, the sheer amount of work done by all
involved agents would represent a significant distraction of
attention and economic resources away from other prob-
lems and solutions that also matter in life (opportunity
cost).
Social and cultural iatrogenesis
The most insidious danger, however, may be what Ivan
Illich termed social and cultural iatrogenesis (Illich 1975):
It may lead to a damaging labelling of aspects of life as
medical and displace other valid goals, values and ways of
understanding and tackling life. Biomedicalization may
distort our understanding of problems that should be
understood on the personal, social or political levels by
describing them in reductive biological terms. The holism
of humanistic medicine has traditionally considered health
a phenomenon that is hard to separate from ‘the good life’
itself (Hofmann 2002; Boenink 2009). When previous
definitions of health have been deliberately ‘vague’, it is
precisely because this phenomenon is exceedingly com-
plex, an enigma defying any simple attempt at a definition
(Gadamer 1996). In accounting for all its critical aspects,
P4SM can never be truly holistic or person-specific. Like
all science it must necessarily involve reduction and gen-
eralization (Vogt et al. 2014; Wolkenhauer 2014). If P4SM
insists that it can eradicate the ‘vagueness’ of health, it also
risks denigrating the ‘the good life’ by ignoring what its
metrics cannot capture. As Downing states of ‘biohealth’
(Downing 2011, p. 6).
Health means wholeness; qualifying it by ‘‘bio-’’
narrows it down to a certain sort of wholeness, that
which is brought about by the application of the
biological sciences. Those applications may be very
beneficial, but those benefits cannot be called health,
because they are not whole.
Critically, while the holism of what we have called
humanistic medicine has focused on what is good enough
in life and exercised a certain tolerance towards disease, we
cannot find the possibility of health being compatible with
disease mentioned in our material. Even more profoundly,
the fact that everyone eventually grows frail and dies—and
how to handle this—is completely absent from P4SM as a
proposed framework. As evident in one of its policy
requirements, P4SM is instead associated with perfection-
ism: ‘Set a benchmark for the U.S. to become the
‘‘healthiest nation’’, like putting a man on the moon’
(Hood and Galas 2008). Evidently, P4SM risks creating
illness-generating and cost-increasing expectations of
wellness (Callahan 1998).
Narratives versus bio-narratives
Our species is biologically defined by an ability to generate
meaningful stories that define our lives and sense of health
(Cassell 2013). What P4SM promises to do through its
continual monitoring and modelling is to redefine such life
stories as what we may call technoscientfically constituted
bio-narratives. In a very real sense, it amounts to a new
‘bio-narrative medicine’, promising literally ‘to develop a
series of stories about how actionable opportunities have
changed the wellness of the participants’ (Hood et al.
2015b). Such bio-narratives may potentially help docu-
ment the importance of personal experience and agency,
but they may also displace other narratives. Consider
remarks made by researchers of the ‘Hundred Person
Wellness Project’:
Almost all individuals came to the study with the
view that they were (for the most part) well. How-
ever, the study exposed for all individuals multiple
actionable possibilities that could be acted upon to
improve their wellness. This illustrated that most of
us have unrealized potential for optimizing our
wellness (Hood et al. 2015b).
These people entered the clinic feeling healthy, but
according to their bio-narrative—as interpreted—they ‘in
fact, have multiple abnormalities in biochemical markers
reflecting organ and system dysfunction, nutritional status
or other health risk’ (Hood et al. 2015a). In this case, each
participant’s experience of health seems trumped by P4SM
metrics. There is no scientific reason, however, why the
bio-narrative should be privileged in defining health. This
is, at least in part, a conceptual question.
The last well person
Hood and coworkers have argued that damaging effects
from risk information and positive findings is ‘a myth’
(Hood et al. 2015a). Rather than going into an empirical
discussion about this disputable conclusion, we will make a
philosophical argument that holistic medicalization must
by necessity have major disruptive effects on human life.
As philosopher Hans-Georg Gadamer puts it, ‘health itself’
is the ability to ‘forget that one is healthy’ (Gadamer 1996,
p vii). This would seem impossible in P4SM. What is at
stake is no less than a person’s own ability to state ‘I am
well’ without having to consult a computational mirror
image. In a 1994 article in The New England Journal of
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Medicine, M.D. Clifton K. Meador satirically predicted the
demise of what he called ‘The Last Well Person’, noting
that ‘Well people are disappearing. (…) I began to realize
what was happening only a year ago, at a dinner party.
Everyone there had something’ (Meador 1994). If P4SM
defines 100 % of the population with something ‘action-
able’, it is risks fulfilling Meador’s prophecy.
Conclusion
We have argued that what we have called the technosci-
entific holism of P4SM points towards a ‘holistic medi-
calization’, to date the most systemetic and comprehensive
expression of a broader ‘medicalization of health and life
itself’ that may also define the limits of medicalization in
the future. With P4SM the ‘divide and conquer’ of previ-
ous reductionist biomedicine is replaced by ‘synthesize and
conquer’. It moves from hoping to control disease by
manipulating of a few factors to hoping to control it
through management of the whole, dynamic life process.
This is not a return to the holism of humanistic medicine,
as in medicine that is focused on the defining capacities,
subjective experience and values of whole persons. Rather,
it is biopsychosocial, patient-centered and person-centered
medicine—or the ‘art’ of medicine—being redrawn in
technoscientific terms.
Despite launching an unprecedented expansion of
medicalization, P4SM advocates have not yet engaged in
judicious discussions of potential downsides. We therefore
want to conclude by affirming that its holism calls for
quaternary prevention. Quaternary prevention is a growing
thrust in preventive medicine aiming to ‘Reduce over-
medicalization (overdiagnosis and overtreatment) and
iatrogenic harm’ through ‘action taken to protect individ-
uals (persons/patients) from medical interventions that are
likely to cause more harm than good’ (Brodersen et al.
2014). The words of biologist Carl Woese (2004) calling
for a new biology for a new century also seem relevant for
health care and preventive measures in the coming years:
‘A society that permits biology to become an engineering
discipline, that allows that science to slip into the role of
changing the living world without trying to understand it, is
a danger to itself’.
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